Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.05013 | 43 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.11298 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.11619 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.454 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.35284 | 56 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.13674 | 45 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.11002 | 45 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.09547 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.0916 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.11398 | 48 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.92583 | 41 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.09798 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.10264 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.10466 | 47 |